

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.31430813 |
| 2 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.99746460 |
| 3 | behavioral response to nicotine (GO:0035095) | 4.88669522 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.80358631 |
| 5 | locomotory exploration behavior (GO:0035641) | 4.58178229 |
| 6 | synaptic vesicle maturation (GO:0016188) | 4.57724686 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 4.45832930 |
| 8 | L-fucose catabolic process (GO:0042355) | 4.44024322 |
| 9 | fucose catabolic process (GO:0019317) | 4.44024322 |
| 10 | L-fucose metabolic process (GO:0042354) | 4.44024322 |
| 11 | kynurenine metabolic process (GO:0070189) | 4.39165924 |
| 12 | vocalization behavior (GO:0071625) | 4.36623310 |
| 13 | tryptophan catabolic process (GO:0006569) | 4.34838322 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 4.34838322 |
| 15 | indolalkylamine catabolic process (GO:0046218) | 4.34838322 |
| 16 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.33902137 |
| 17 | glutamate secretion (GO:0014047) | 4.33584263 |
| 18 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.31791674 |
| 19 | neuron cell-cell adhesion (GO:0007158) | 4.28282029 |
| 20 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.26929329 |
| 21 | glutamate receptor signaling pathway (GO:0007215) | 4.21890445 |
| 22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.17302107 |
| 23 | indolalkylamine metabolic process (GO:0006586) | 4.16817988 |
| 24 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.08815712 |
| 25 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.08059436 |
| 26 | synaptic transmission, glutamatergic (GO:0035249) | 4.03330655 |
| 27 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.01089726 |
| 28 | protein localization to synapse (GO:0035418) | 3.93274105 |
| 29 | regulation of synaptic vesicle transport (GO:1902803) | 3.88214589 |
| 30 | cellular ketone body metabolic process (GO:0046950) | 3.86866741 |
| 31 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.86652904 |
| 32 | detection of light stimulus involved in visual perception (GO:0050908) | 3.77087654 |
| 33 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.77087654 |
| 34 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.71697008 |
| 35 | membrane depolarization during action potential (GO:0086010) | 3.71428781 |
| 36 | neuron-neuron synaptic transmission (GO:0007270) | 3.70320702 |
| 37 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.64057525 |
| 38 | cellular potassium ion homeostasis (GO:0030007) | 3.59539415 |
| 39 | exploration behavior (GO:0035640) | 3.58647249 |
| 40 | snRNA transcription (GO:0009301) | 3.57821134 |
| 41 | tryptophan metabolic process (GO:0006568) | 3.55161625 |
| 42 | signal peptide processing (GO:0006465) | 3.52182107 |
| 43 | protein K11-linked deubiquitination (GO:0035871) | 3.52069890 |
| 44 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.51347867 |
| 45 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.50462656 |
| 46 | long-term memory (GO:0007616) | 3.48843285 |
| 47 | neurotransmitter secretion (GO:0007269) | 3.47204612 |
| 48 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.45788652 |
| 49 | ketone body metabolic process (GO:1902224) | 3.45645234 |
| 50 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.44876611 |
| 51 | indole-containing compound metabolic process (GO:0042430) | 3.37915538 |
| 52 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.34945291 |
| 53 | neuronal action potential propagation (GO:0019227) | 3.33051298 |
| 54 | regulation of hippo signaling (GO:0035330) | 3.31296586 |
| 55 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.31073252 |
| 56 | synaptic vesicle endocytosis (GO:0048488) | 3.30775886 |
| 57 | response to pheromone (GO:0019236) | 3.30432036 |
| 58 | gamma-aminobutyric acid transport (GO:0015812) | 3.29075087 |
| 59 | presynaptic membrane assembly (GO:0097105) | 3.27696622 |
| 60 | positive regulation of membrane potential (GO:0045838) | 3.24439092 |
| 61 | piRNA metabolic process (GO:0034587) | 3.23581951 |
| 62 | DNA methylation involved in gamete generation (GO:0043046) | 3.22940527 |
| 63 | regulation of postsynaptic membrane potential (GO:0060078) | 3.22244748 |
| 64 | negative regulation of mast cell activation (GO:0033004) | 3.21540408 |
| 65 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.20914333 |
| 66 | primary amino compound metabolic process (GO:1901160) | 3.20635167 |
| 67 | serotonin metabolic process (GO:0042428) | 3.20395012 |
| 68 | dendrite morphogenesis (GO:0048813) | 3.19447281 |
| 69 | oxidative demethylation (GO:0070989) | 3.18829250 |
| 70 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.17419946 |
| 71 | axoneme assembly (GO:0035082) | 3.17245349 |
| 72 | detection of calcium ion (GO:0005513) | 3.14946554 |
| 73 | neuron recognition (GO:0008038) | 3.13947458 |
| 74 | regulation of vesicle fusion (GO:0031338) | 3.11205227 |
| 75 | regulation of synapse structural plasticity (GO:0051823) | 3.10774637 |
| 76 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.09326331 |
| 77 | calcium ion import (GO:0070509) | 3.08836091 |
| 78 | regulation of neurotransmitter secretion (GO:0046928) | 3.07242366 |
| 79 | membrane depolarization (GO:0051899) | 3.06823062 |
| 80 | positive regulation of synapse maturation (GO:0090129) | 3.06599766 |
| 81 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.05777755 |
| 82 | axonal fasciculation (GO:0007413) | 3.04166376 |
| 83 | DNA deamination (GO:0045006) | 3.04132238 |
| 84 | calcium ion-dependent exocytosis (GO:0017156) | 3.02818821 |
| 85 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.02650390 |
| 86 | dendritic spine morphogenesis (GO:0060997) | 3.02609217 |
| 87 | innervation (GO:0060384) | 3.02518949 |
| 88 | vesicle transport along microtubule (GO:0047496) | 3.02125334 |
| 89 | long-term synaptic potentiation (GO:0060291) | 3.01156232 |
| 90 | cellular response to ATP (GO:0071318) | 3.00973133 |
| 91 | activation of protein kinase A activity (GO:0034199) | 3.00926585 |
| 92 | neural tube formation (GO:0001841) | 3.00779003 |
| 93 | transmission of nerve impulse (GO:0019226) | 3.00516918 |
| 94 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.98885798 |
| 95 | sodium ion export (GO:0071436) | 2.97288067 |
| 96 | interkinetic nuclear migration (GO:0022027) | 2.95254311 |
| 97 | postsynaptic membrane organization (GO:0001941) | 2.95173177 |
| 98 | presynaptic membrane organization (GO:0097090) | 2.94681851 |
| 99 | startle response (GO:0001964) | 2.94544247 |
| 100 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.94421437 |
| 101 | adaptation of signaling pathway (GO:0023058) | 2.93980653 |
| 102 | regulation of synaptic plasticity (GO:0048167) | 2.93053164 |
| 103 | protein polyglutamylation (GO:0018095) | 2.92090388 |
| 104 | neuronal action potential (GO:0019228) | 2.91737211 |
| 105 | neurotransmitter transport (GO:0006836) | 2.90921681 |
| 106 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.89936622 |
| 107 | cerebellar granule cell differentiation (GO:0021707) | 2.89300779 |
| 108 | regulation of action potential (GO:0098900) | 2.88586453 |
| 109 | layer formation in cerebral cortex (GO:0021819) | 2.88387324 |
| 110 | L-amino acid import (GO:0043092) | 2.86609168 |
| 111 | proline transport (GO:0015824) | 2.85881417 |
| 112 | regulation of ARF protein signal transduction (GO:0032012) | 2.85209965 |
| 113 | sulfation (GO:0051923) | 2.85148871 |
| 114 | epithelial cilium movement (GO:0003351) | 2.84420426 |
| 115 | membrane hyperpolarization (GO:0060081) | 2.84141915 |
| 116 | reflex (GO:0060004) | 2.83012545 |
| 117 | cell communication by electrical coupling (GO:0010644) | 2.82604722 |
| 118 | response to auditory stimulus (GO:0010996) | 2.81658548 |
| 119 | nerve growth factor signaling pathway (GO:0038180) | 2.81086633 |
| 120 | response to histamine (GO:0034776) | 2.81002369 |
| 121 | regulation of neurotransmitter transport (GO:0051588) | 2.79606354 |
| 122 | chemosensory behavior (GO:0007635) | 2.78249464 |
| 123 | benzene-containing compound metabolic process (GO:0042537) | 2.78137798 |
| 124 | cellular sodium ion homeostasis (GO:0006883) | 2.77533523 |
| 125 | negative regulation of sodium ion transport (GO:0010766) | 2.77443826 |
| 126 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.75421549 |
| 127 | adult walking behavior (GO:0007628) | 2.75409072 |
| 128 | prepulse inhibition (GO:0060134) | 2.75283929 |
| 129 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.74774155 |
| 130 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.72371597 |
| 131 | cellular biogenic amine catabolic process (GO:0042402) | 2.71774227 |
| 132 | amine catabolic process (GO:0009310) | 2.71774227 |
| 133 | aromatic amino acid family catabolic process (GO:0009074) | 2.71365922 |
| 134 | cilium movement (GO:0003341) | 2.70583685 |
| 135 | synapse assembly (GO:0007416) | 2.70558472 |
| 136 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.70223926 |
| 137 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.70148371 |
| 138 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.69132590 |
| 139 | kidney morphogenesis (GO:0060993) | 2.68329310 |
| 140 | glycerophospholipid catabolic process (GO:0046475) | 2.68216571 |
| 141 | rhodopsin mediated signaling pathway (GO:0016056) | 2.68187923 |
| 142 | long term synaptic depression (GO:0060292) | 2.68032976 |
| 143 | striatum development (GO:0021756) | 2.66625831 |
| 144 | neuromuscular process controlling posture (GO:0050884) | 2.63188765 |
| 145 | photoreceptor cell maintenance (GO:0045494) | 2.62226229 |
| 146 | multicellular organism reproduction (GO:0032504) | 2.62223041 |
| 147 | synaptic transmission (GO:0007268) | 2.61313801 |
| 148 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.61167364 |
| 149 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.60546558 |
| 150 | dopamine transport (GO:0015872) | 2.59651531 |
| 151 | neuromuscular process controlling balance (GO:0050885) | 2.59122370 |
| 152 | retinal cone cell development (GO:0046549) | 2.58839009 |
| 153 | cAMP catabolic process (GO:0006198) | 2.57687667 |
| 154 | regulation of neurotransmitter levels (GO:0001505) | 2.56960145 |
| 155 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.56835399 |
| 156 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.56304727 |
| 157 | organelle transport along microtubule (GO:0072384) | 2.56167859 |
| 158 | learning (GO:0007612) | 2.55444979 |
| 159 | regulation of glucokinase activity (GO:0033131) | 2.55023994 |
| 160 | regulation of hexokinase activity (GO:1903299) | 2.55023994 |
| 161 | synapsis (GO:0007129) | 2.54278661 |
| 162 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.54074572 |
| 163 | double-strand break repair via homologous recombination (GO:0000724) | 2.54010140 |
| 164 | cilium organization (GO:0044782) | 2.53154448 |
| 165 | recombinational repair (GO:0000725) | 2.51860295 |
| 166 | reciprocal meiotic recombination (GO:0007131) | 2.51567274 |
| 167 | reciprocal DNA recombination (GO:0035825) | 2.51567274 |
| 168 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.50083367 |
| 169 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.50083367 |
| 170 | male meiosis I (GO:0007141) | 2.49883118 |
| 171 | behavioral response to ethanol (GO:0048149) | 2.48904705 |
| 172 | nonmotile primary cilium assembly (GO:0035058) | 2.47736787 |
| 173 | neurotransmitter metabolic process (GO:0042133) | 2.46689193 |
| 174 | cilium assembly (GO:0042384) | 2.46308652 |
| 175 | insulin secretion (GO:0030073) | 2.45428872 |
| 176 | platelet dense granule organization (GO:0060155) | 2.45253238 |
| 177 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.44442831 |
| 178 | cornea development in camera-type eye (GO:0061303) | 2.44200945 |
| 179 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.44069203 |
| 180 | negative regulation of telomere maintenance (GO:0032205) | 2.43751891 |
| 181 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.43009408 |
| 182 | regulation of cilium movement (GO:0003352) | 2.42449503 |
| 183 | NAD biosynthetic process (GO:0009435) | 2.41927515 |
| 184 | methionine biosynthetic process (GO:0009086) | 2.41267774 |
| 185 | spinal cord motor neuron differentiation (GO:0021522) | 2.41019386 |
| 186 | aromatic amino acid family metabolic process (GO:0009072) | 2.39968688 |
| 187 | cyclic nucleotide catabolic process (GO:0009214) | 2.38811902 |
| 188 | respiratory chain complex IV assembly (GO:0008535) | 2.38151607 |
| 189 | establishment of protein localization to Golgi (GO:0072600) | 2.37686357 |
| 190 | cilium morphogenesis (GO:0060271) | 2.36650024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.01348705 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.85253224 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.84925447 |
| 4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.49032037 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.44137513 |
| 6 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.35318546 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.33778968 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.27377413 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.26771698 |
| 10 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.09736244 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.09058800 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.02922456 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.00384357 |
| 14 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.97703511 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.95316540 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.95316540 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.94932389 |
| 18 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.92295281 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.89932216 |
| 20 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.89318017 |
| 21 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.88836914 |
| 22 | EWS_26573619_Chip-Seq_HEK293_Human | 1.85898846 |
| 23 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.85861312 |
| 24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.85693978 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.83323449 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.81480421 |
| 27 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.78868273 |
| 28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.76627295 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.76494560 |
| 30 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.75716617 |
| 31 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.74629012 |
| 32 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.72471651 |
| 33 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.69985833 |
| 34 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.69864121 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.69271655 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.68717985 |
| 37 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.67765996 |
| 38 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.66467826 |
| 39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.61052427 |
| 40 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.58439655 |
| 41 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.56458196 |
| 42 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.55387575 |
| 43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54952546 |
| 44 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.48997266 |
| 45 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.48918922 |
| 46 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.48838337 |
| 47 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.48588104 |
| 48 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.48029695 |
| 49 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.48029695 |
| 50 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.46066315 |
| 51 | P300_19829295_ChIP-Seq_ESCs_Human | 1.45362681 |
| 52 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.44318637 |
| 53 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.42187156 |
| 54 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.41633909 |
| 55 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.41518743 |
| 56 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.41312995 |
| 57 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.39596502 |
| 58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.39387738 |
| 59 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.37458285 |
| 60 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37327463 |
| 61 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.37271634 |
| 62 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.37103114 |
| 63 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.35882459 |
| 64 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.35853430 |
| 65 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.34170215 |
| 66 | TCF4_23295773_ChIP-Seq_U87_Human | 1.33935108 |
| 67 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33374612 |
| 68 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.32949277 |
| 69 | AR_25329375_ChIP-Seq_VCAP_Human | 1.32235165 |
| 70 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.32043894 |
| 71 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.32043894 |
| 72 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.29446981 |
| 73 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28711826 |
| 74 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.28537844 |
| 75 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.27598541 |
| 76 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.26130877 |
| 77 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.25229983 |
| 78 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.24317776 |
| 79 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.23596358 |
| 80 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.23306259 |
| 81 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23187277 |
| 82 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.22714282 |
| 83 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.22697209 |
| 84 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22635421 |
| 85 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.22233939 |
| 86 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.21943734 |
| 87 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.21927370 |
| 88 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21692653 |
| 89 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.21213379 |
| 90 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.20881251 |
| 91 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.20881251 |
| 92 | AR_19668381_ChIP-Seq_PC3_Human | 1.17741596 |
| 93 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.17284811 |
| 94 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17284811 |
| 95 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.17040935 |
| 96 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17030921 |
| 97 | TP53_16413492_ChIP-PET_HCT116_Human | 1.16869048 |
| 98 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.15150368 |
| 99 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.14981680 |
| 100 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.14440302 |
| 101 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.13739886 |
| 102 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12794951 |
| 103 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.12351086 |
| 104 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.11677127 |
| 105 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.11266320 |
| 106 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.10925774 |
| 107 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.10592713 |
| 108 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10265389 |
| 109 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.10114117 |
| 110 | FUS_26573619_Chip-Seq_HEK293_Human | 1.09796008 |
| 111 | NCOR_22424771_ChIP-Seq_293T_Human | 1.08034391 |
| 112 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08002951 |
| 113 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07762820 |
| 114 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.07405974 |
| 115 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07302060 |
| 116 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.07176934 |
| 117 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.05860060 |
| 118 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.05805708 |
| 119 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.05692130 |
| 120 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.05108909 |
| 121 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04797079 |
| 122 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.04253240 |
| 123 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.03812678 |
| 124 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03548338 |
| 125 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.03543271 |
| 126 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02933078 |
| 127 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.02264456 |
| 128 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.01133262 |
| 129 | KDM2B_26808549_Chip-Seq_REH_Human | 1.01131699 |
| 130 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00952825 |
| 131 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.00627407 |
| 132 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99607164 |
| 133 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98995471 |
| 134 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.98682693 |
| 135 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97857043 |
| 136 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97587934 |
| 137 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.97135549 |
| 138 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.96360149 |
| 139 | VDR_22108803_ChIP-Seq_LS180_Human | 0.95583584 |
| 140 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95549298 |
| 141 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.94813652 |
| 142 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94143456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.90210958 |
| 2 | MP0003880_abnormal_central_pattern | 4.25473125 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.83871220 |
| 4 | MP0004270_analgesia | 3.59409370 |
| 5 | MP0003195_calcinosis | 3.25905004 |
| 6 | MP0009046_muscle_twitch | 3.21769890 |
| 7 | MP0009745_abnormal_behavioral_response | 3.13506491 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.04985970 |
| 9 | MP0002064_seizures | 2.91932364 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.69567967 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.66578986 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.64454588 |
| 13 | MP0000569_abnormal_digit_pigmentation | 2.60626435 |
| 14 | MP0001984_abnormal_olfaction | 2.53269017 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.52220427 |
| 16 | MP0002272_abnormal_nervous_system | 2.50246925 |
| 17 | MP0001486_abnormal_startle_reflex | 2.46990233 |
| 18 | MP0003646_muscle_fatigue | 2.34405053 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.32628018 |
| 20 | MP0003787_abnormal_imprinting | 2.24271280 |
| 21 | MP0001501_abnormal_sleep_pattern | 2.23946913 |
| 22 | MP0002909_abnormal_adrenal_gland | 2.03060105 |
| 23 | MP0002067_abnormal_sensory_capabilities | 1.98896333 |
| 24 | MP0002736_abnormal_nociception_after | 1.98894029 |
| 25 | MP0001986_abnormal_taste_sensitivity | 1.97074821 |
| 26 | MP0002822_catalepsy | 1.95053381 |
| 27 | MP0005551_abnormal_eye_electrophysiolog | 1.89120869 |
| 28 | MP0001440_abnormal_grooming_behavior | 1.85214315 |
| 29 | MP0005646_abnormal_pituitary_gland | 1.84613247 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.82707475 |
| 31 | MP0005174_abnormal_tail_pigmentation | 1.80992534 |
| 32 | MP0000427_abnormal_hair_cycle | 1.80295102 |
| 33 | MP0008057_abnormal_DNA_replication | 1.79638565 |
| 34 | MP0008569_lethality_at_weaning | 1.78627785 |
| 35 | MP0002733_abnormal_thermal_nociception | 1.77999989 |
| 36 | MP0002184_abnormal_innervation | 1.77816890 |
| 37 | MP0000778_abnormal_nervous_system | 1.77682164 |
| 38 | MP0001970_abnormal_pain_threshold | 1.76916155 |
| 39 | MP0001502_abnormal_circadian_rhythm | 1.68649762 |
| 40 | MP0002557_abnormal_social/conspecific_i | 1.61407666 |
| 41 | MP0005645_abnormal_hypothalamus_physiol | 1.60230891 |
| 42 | MP0010386_abnormal_urinary_bladder | 1.57562426 |
| 43 | MP0008875_abnormal_xenobiotic_pharmacok | 1.55223423 |
| 44 | MP0003879_abnormal_hair_cell | 1.54696372 |
| 45 | MP0004924_abnormal_behavior | 1.54175584 |
| 46 | MP0005386_behavior/neurological_phenoty | 1.54175584 |
| 47 | MP0000383_abnormal_hair_follicle | 1.53721437 |
| 48 | MP0002102_abnormal_ear_morphology | 1.51378869 |
| 49 | MP0004858_abnormal_nervous_system | 1.50093612 |
| 50 | MP0004811_abnormal_neuron_physiology | 1.48943636 |
| 51 | MP0002882_abnormal_neuron_morphology | 1.45136701 |
| 52 | MP0003633_abnormal_nervous_system | 1.43221034 |
| 53 | MP0000955_abnormal_spinal_cord | 1.36832614 |
| 54 | MP0002160_abnormal_reproductive_system | 1.36763202 |
| 55 | MP0002229_neurodegeneration | 1.33116375 |
| 56 | MP0006292_abnormal_olfactory_placode | 1.31741709 |
| 57 | MP0005379_endocrine/exocrine_gland_phen | 1.30026936 |
| 58 | MP0005389_reproductive_system_phenotype | 1.29828257 |
| 59 | MP0002066_abnormal_motor_capabilities/c | 1.29712389 |
| 60 | MP0003329_amyloid_beta_deposits | 1.27168116 |
| 61 | MP0000372_irregular_coat_pigmentation | 1.25087759 |
| 62 | MP0002163_abnormal_gland_morphology | 1.25059118 |
| 63 | MP0004510_myositis | 1.23741042 |
| 64 | MP0006276_abnormal_autonomic_nervous | 1.22954263 |
| 65 | MP0004145_abnormal_muscle_electrophysio | 1.22023553 |
| 66 | MP0005410_abnormal_fertilization | 1.21960938 |
| 67 | MP0003136_yellow_coat_color | 1.19807239 |
| 68 | MP0004130_abnormal_muscle_cell | 1.19403531 |
| 69 | MP0002938_white_spotting | 1.18893419 |
| 70 | MP0000015_abnormal_ear_pigmentation | 1.17330189 |
| 71 | MP0003718_maternal_effect | 1.16959284 |
| 72 | MP0004885_abnormal_endolymph | 1.15913042 |
| 73 | MP0003631_nervous_system_phenotype | 1.15380202 |
| 74 | MP0005171_absent_coat_pigmentation | 1.13962993 |
| 75 | MP0001905_abnormal_dopamine_level | 1.12911042 |
| 76 | MP0004133_heterotaxia | 1.12242366 |
| 77 | MP0000538_abnormal_urinary_bladder | 1.11699739 |
| 78 | MP0010329_abnormal_lipoprotein_level | 1.10894389 |
| 79 | MP0004142_abnormal_muscle_tone | 1.10271249 |
| 80 | MP0002095_abnormal_skin_pigmentation | 1.08676628 |
| 81 | MP0005310_abnormal_salivary_gland | 1.08608156 |
| 82 | MP0001944_abnormal_pancreas_morphology | 1.08343094 |
| 83 | MP0003045_fibrosis | 1.07582181 |
| 84 | MP0003183_abnormal_peptide_metabolism | 1.07329502 |
| 85 | MP0001188_hyperpigmentation | 1.06993949 |
| 86 | MP0006072_abnormal_retinal_apoptosis | 1.06154275 |
| 87 | MP0003252_abnormal_bile_duct | 1.05943836 |
| 88 | MP0003283_abnormal_digestive_organ | 1.03253066 |
| 89 | MP0002090_abnormal_vision | 1.02651926 |
| 90 | MP0004147_increased_porphyrin_level | 1.02518416 |
| 91 | MP0010678_abnormal_skin_adnexa | 1.02215111 |
| 92 | MP0003011_delayed_dark_adaptation | 1.01015893 |
| 93 | MP0002928_abnormal_bile_duct | 1.00503384 |
| 94 | MP0002152_abnormal_brain_morphology | 0.99318728 |
| 95 | MP0005253_abnormal_eye_physiology | 0.98022766 |
| 96 | MP0003690_abnormal_glial_cell | 0.97906498 |
| 97 | MP0005266_abnormal_metabolism | 0.96900124 |
| 98 | MP0003634_abnormal_glial_cell | 0.96880431 |
| 99 | MP0005075_abnormal_melanosome_morpholog | 0.96578399 |
| 100 | MP0003172_abnormal_lysosome_physiology | 0.95686949 |
| 101 | MP0001529_abnormal_vocalization | 0.94335501 |
| 102 | MP0005085_abnormal_gallbladder_physiolo | 0.92533044 |
| 103 | MP0008877_abnormal_DNA_methylation | 0.92342924 |
| 104 | MP0004742_abnormal_vestibular_system | 0.91896311 |
| 105 | MP0002138_abnormal_hepatobiliary_system | 0.91274665 |
| 106 | MP0000230_abnormal_systemic_arterial | 0.90118367 |
| 107 | MP0000920_abnormal_myelination | 0.88244563 |
| 108 | MP0002752_abnormal_somatic_nervous | 0.86970060 |
| 109 | MP0002837_dystrophic_cardiac_calcinosis | 0.86813284 |
| 110 | MP0008995_early_reproductive_senescence | 0.86615319 |
| 111 | MP0002638_abnormal_pupillary_reflex | 0.85939054 |
| 112 | MP0008961_abnormal_basal_metabolism | 0.85830268 |
| 113 | MP0005332_abnormal_amino_acid | 0.85746382 |
| 114 | MP0001929_abnormal_gametogenesis | 0.84785864 |
| 115 | MP0000013_abnormal_adipose_tissue | 0.84430364 |
| 116 | MP0001919_abnormal_reproductive_system | 0.84360003 |
| 117 | MP0004085_abnormal_heartbeat | 0.82220283 |
| 118 | MP0003122_maternal_imprinting | 0.82015252 |
| 119 | MP0001299_abnormal_eye_distance/ | 0.81504544 |
| 120 | MP0002069_abnormal_eating/drinking_beha | 0.80858998 |
| 121 | MP0005499_abnormal_olfactory_system | 0.80684735 |
| 122 | MP0005394_taste/olfaction_phenotype | 0.80684735 |
| 123 | MP0005535_abnormal_body_temperature | 0.79634369 |
| 124 | MP0001765_abnormal_ion_homeostasis | 0.79396047 |
| 125 | MP0003632_abnormal_nervous_system | 0.79270522 |
| 126 | MP0003075_altered_response_to | 0.78557312 |
| 127 | MP0002653_abnormal_ependyma_morphology | 0.78369951 |
| 128 | MP0002210_abnormal_sex_determination | 0.77972724 |
| 129 | MP0004043_abnormal_pH_regulation | 0.77091489 |
| 130 | MP0010234_abnormal_vibrissa_follicle | 0.76893864 |
| 131 | MP0005448_abnormal_energy_balance | 0.76758613 |
| 132 | MP0000631_abnormal_neuroendocrine_gland | 0.75371446 |
| 133 | MP0003953_abnormal_hormone_level | 0.74942106 |
| 134 | MP0001963_abnormal_hearing_physiology | 0.72271977 |
| 135 | MP0004215_abnormal_myocardial_fiber | 0.69946375 |
| 136 | MP0008874_decreased_physiological_sensi | 0.69826739 |
| 137 | MP0002693_abnormal_pancreas_physiology | 0.68048904 |
| 138 | MP0000751_myopathy | 0.67742918 |
| 139 | MP0005195_abnormal_posterior_eye | 0.65949970 |
| 140 | MP0001485_abnormal_pinna_reflex | 0.65229260 |
| 141 | MP0003137_abnormal_impulse_conducting | 0.63359612 |
| 142 | MP0003698_abnormal_male_reproductive | 0.63165916 |
| 143 | MP0002876_abnormal_thyroid_physiology | 0.59593163 |
| 144 | MP0001177_atelectasis | 0.59235284 |
| 145 | MP0008872_abnormal_physiological_respon | 0.59054348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.05401638 |
| 2 | Focal seizures (HP:0007359) | 4.92283812 |
| 3 | Epileptic encephalopathy (HP:0200134) | 4.68776634 |
| 4 | Pancreatic cysts (HP:0001737) | 4.52991855 |
| 5 | Febrile seizures (HP:0002373) | 4.51010693 |
| 6 | Atonic seizures (HP:0010819) | 4.30887602 |
| 7 | Myokymia (HP:0002411) | 4.25518591 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.15988044 |
| 9 | Pancreatic fibrosis (HP:0100732) | 4.10141531 |
| 10 | Visual hallucinations (HP:0002367) | 3.92765766 |
| 11 | True hermaphroditism (HP:0010459) | 3.85174866 |
| 12 | Absence seizures (HP:0002121) | 3.83271812 |
| 13 | Molar tooth sign on MRI (HP:0002419) | 3.71814328 |
| 14 | Abnormality of midbrain morphology (HP:0002418) | 3.71814328 |
| 15 | Dialeptic seizures (HP:0011146) | 3.57444779 |
| 16 | Action tremor (HP:0002345) | 3.49312008 |
| 17 | Abnormality of the renal cortex (HP:0011035) | 3.41872541 |
| 18 | Gaze-evoked nystagmus (HP:0000640) | 3.41630454 |
| 19 | Generalized tonic-clonic seizures (HP:0002069) | 3.36409996 |
| 20 | Supranuclear gaze palsy (HP:0000605) | 3.34560744 |
| 21 | Broad-based gait (HP:0002136) | 3.29090966 |
| 22 | Nephronophthisis (HP:0000090) | 3.27358659 |
| 23 | Chronic hepatic failure (HP:0100626) | 3.23081312 |
| 24 | Truncal ataxia (HP:0002078) | 3.14379865 |
| 25 | Large for gestational age (HP:0001520) | 3.00221841 |
| 26 | Type II lissencephaly (HP:0007260) | 2.98399589 |
| 27 | Dysdiadochokinesis (HP:0002075) | 2.98191130 |
| 28 | Dysmetria (HP:0001310) | 2.98078067 |
| 29 | Central scotoma (HP:0000603) | 2.97795570 |
| 30 | Abnormality of the renal medulla (HP:0100957) | 2.93244872 |
| 31 | Cystic liver disease (HP:0006706) | 2.89704923 |
| 32 | Genetic anticipation (HP:0003743) | 2.88836772 |
| 33 | Excessive salivation (HP:0003781) | 2.81498814 |
| 34 | Drooling (HP:0002307) | 2.81498814 |
| 35 | Impaired smooth pursuit (HP:0007772) | 2.80023002 |
| 36 | Inability to walk (HP:0002540) | 2.79638923 |
| 37 | Tubular atrophy (HP:0000092) | 2.78216369 |
| 38 | Hemiparesis (HP:0001269) | 2.77880607 |
| 39 | Attenuation of retinal blood vessels (HP:0007843) | 2.75757855 |
| 40 | Abolished electroretinogram (ERG) (HP:0000550) | 2.73965792 |
| 41 | Furrowed tongue (HP:0000221) | 2.73441543 |
| 42 | Ankle clonus (HP:0011448) | 2.70665493 |
| 43 | Hyperventilation (HP:0002883) | 2.69742084 |
| 44 | Abnormal drinking behavior (HP:0030082) | 2.67310495 |
| 45 | Polydipsia (HP:0001959) | 2.67310495 |
| 46 | Absent/shortened dynein arms (HP:0200106) | 2.67136643 |
| 47 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.67136643 |
| 48 | Epileptiform EEG discharges (HP:0011182) | 2.65665555 |
| 49 | Decreased circulating renin level (HP:0003351) | 2.65253914 |
| 50 | Congenital, generalized hypertrichosis (HP:0004540) | 2.63840479 |
| 51 | Neurofibrillary tangles (HP:0002185) | 2.63813522 |
| 52 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.62672146 |
| 53 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.57086087 |
| 54 | Congenital stationary night blindness (HP:0007642) | 2.55402131 |
| 55 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.54837634 |
| 56 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.54030462 |
| 57 | Postural instability (HP:0002172) | 2.51154240 |
| 58 | Abnormality of macular pigmentation (HP:0008002) | 2.50934587 |
| 59 | Abnormality of alanine metabolism (HP:0010916) | 2.49901083 |
| 60 | Hyperalaninemia (HP:0003348) | 2.49901083 |
| 61 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.49901083 |
| 62 | Mutism (HP:0002300) | 2.49191873 |
| 63 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.48389161 |
| 64 | Gait imbalance (HP:0002141) | 2.47567201 |
| 65 | EEG with generalized epileptiform discharges (HP:0011198) | 2.47032440 |
| 66 | Fair hair (HP:0002286) | 2.45973537 |
| 67 | Depression (HP:0000716) | 2.45114174 |
| 68 | Increased circulating renin level (HP:0000848) | 2.44831607 |
| 69 | Renal cortical cysts (HP:0000803) | 2.43436377 |
| 70 | Ketoacidosis (HP:0001993) | 2.41397411 |
| 71 | Pendular nystagmus (HP:0012043) | 2.35066834 |
| 72 | Absent speech (HP:0001344) | 2.34213950 |
| 73 | Cerebral inclusion bodies (HP:0100314) | 2.30981822 |
| 74 | Diplopia (HP:0000651) | 2.30206056 |
| 75 | Abnormality of binocular vision (HP:0011514) | 2.30206056 |
| 76 | Clumsiness (HP:0002312) | 2.27433618 |
| 77 | Blue irides (HP:0000635) | 2.27346740 |
| 78 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.26318032 |
| 79 | Widely spaced teeth (HP:0000687) | 2.26239373 |
| 80 | Spastic gait (HP:0002064) | 2.25512702 |
| 81 | Abnormality of the corticospinal tract (HP:0002492) | 2.25007141 |
| 82 | Hypoplasia of the pons (HP:0012110) | 2.23758516 |
| 83 | Hypsarrhythmia (HP:0002521) | 2.22981825 |
| 84 | Protruding tongue (HP:0010808) | 2.21511827 |
| 85 | Congenital sensorineural hearing impairment (HP:0008527) | 2.21264283 |
| 86 | Abnormality of the pons (HP:0007361) | 2.20009880 |
| 87 | Sclerocornea (HP:0000647) | 2.18949481 |
| 88 | Ketosis (HP:0001946) | 2.17323147 |
| 89 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.17193462 |
| 90 | Anxiety (HP:0000739) | 2.14541520 |
| 91 | Medial flaring of the eyebrow (HP:0010747) | 2.14467020 |
| 92 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.12875118 |
| 93 | Congenital primary aphakia (HP:0007707) | 2.11878663 |
| 94 | Intention tremor (HP:0002080) | 2.11855536 |
| 95 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.10507719 |
| 96 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.09960956 |
| 97 | Patellar aplasia (HP:0006443) | 2.07585027 |
| 98 | Dysmetric saccades (HP:0000641) | 2.06820978 |
| 99 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.06792152 |
| 100 | Chorioretinal atrophy (HP:0000533) | 2.06777894 |
| 101 | Amblyopia (HP:0000646) | 2.06714518 |
| 102 | Abnormal eating behavior (HP:0100738) | 2.05875379 |
| 103 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.05788550 |
| 104 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.05788550 |
| 105 | Poor eye contact (HP:0000817) | 2.05269529 |
| 106 | Abnormality of salivation (HP:0100755) | 2.04529264 |
| 107 | Increased corneal curvature (HP:0100692) | 2.04453008 |
| 108 | Keratoconus (HP:0000563) | 2.04453008 |
| 109 | Lissencephaly (HP:0001339) | 2.04426298 |
| 110 | Scanning speech (HP:0002168) | 2.04164094 |
| 111 | Lower limb muscle weakness (HP:0007340) | 2.03866805 |
| 112 | Papilledema (HP:0001085) | 2.02759798 |
| 113 | Bile duct proliferation (HP:0001408) | 2.02448395 |
| 114 | Abnormal biliary tract physiology (HP:0012439) | 2.02448395 |
| 115 | Nephrogenic diabetes insipidus (HP:0009806) | 2.02370550 |
| 116 | Polyuria (HP:0000103) | 2.02291049 |
| 117 | Congenital hepatic fibrosis (HP:0002612) | 2.00989648 |
| 118 | Male pseudohermaphroditism (HP:0000037) | 2.00745546 |
| 119 | Hyperkalemia (HP:0002153) | 1.99163323 |
| 120 | Hemiplegia (HP:0002301) | 1.99111881 |
| 121 | Cerebellar dysplasia (HP:0007033) | 1.97904107 |
| 122 | Anencephaly (HP:0002323) | 1.97715528 |
| 123 | Stereotypic behavior (HP:0000733) | 1.95012495 |
| 124 | Hypothermia (HP:0002045) | 1.94922342 |
| 125 | Decreased central vision (HP:0007663) | 1.93982337 |
| 126 | Impaired social interactions (HP:0000735) | 1.93578262 |
| 127 | Abnormal social behavior (HP:0012433) | 1.93578262 |
| 128 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.93091845 |
| 129 | Prolonged QT interval (HP:0001657) | 1.90257374 |
| 130 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.89845475 |
| 131 | Abnormality of the lower motor neuron (HP:0002366) | 1.89541557 |
| 132 | Inappropriate behavior (HP:0000719) | 1.89061934 |
| 133 | Abnormality of saccadic eye movements (HP:0000570) | 1.88884648 |
| 134 | Neuronal loss in central nervous system (HP:0002529) | 1.88037823 |
| 135 | Ventricular fibrillation (HP:0001663) | 1.87673123 |
| 136 | Syncope (HP:0001279) | 1.87176191 |
| 137 | Bradykinesia (HP:0002067) | 1.83562836 |
| 138 | Progressive inability to walk (HP:0002505) | 1.82416544 |
| 139 | Termporal pattern (HP:0011008) | 1.81870294 |
| 140 | Insidious onset (HP:0003587) | 1.81870294 |
| 141 | Abnormal ciliary motility (HP:0012262) | 1.81006240 |
| 142 | Postaxial foot polydactyly (HP:0001830) | 1.80398663 |
| 143 | Intestinal atresia (HP:0011100) | 1.79915770 |
| 144 | Hypomagnesemia (HP:0002917) | 1.79816675 |
| 145 | Retinal dysplasia (HP:0007973) | 1.79581302 |
| 146 | Impaired vibratory sensation (HP:0002495) | 1.79051112 |
| 147 | Bradycardia (HP:0001662) | 1.78792223 |
| 148 | Specific learning disability (HP:0001328) | 1.78222653 |
| 149 | Choroideremia (HP:0001139) | 1.77690005 |
| 150 | Lower limb amyotrophy (HP:0007210) | 1.77414134 |
| 151 | Open mouth (HP:0000194) | 1.76922037 |
| 152 | Abnormal albumin level (HP:0012116) | 1.76563942 |
| 153 | Hypoalbuminemia (HP:0003073) | 1.76563942 |
| 154 | Abnormal EKG (HP:0003115) | 1.76548470 |
| 155 | Generalized hypopigmentation of hair (HP:0011358) | 1.76358888 |
| 156 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.75113361 |
| 157 | Urinary urgency (HP:0000012) | 1.74099798 |
| 158 | Genital tract atresia (HP:0001827) | 1.73825923 |
| 159 | Agitation (HP:0000713) | 1.73672631 |
| 160 | Scotoma (HP:0000575) | 1.73612814 |
| 161 | Hyperphosphatemia (HP:0002905) | 1.73568137 |
| 162 | Oligodactyly (hands) (HP:0001180) | 1.73230800 |
| 163 | Severe muscular hypotonia (HP:0006829) | 1.70858226 |
| 164 | Neoplasm of the adrenal cortex (HP:0100641) | 1.69575958 |
| 165 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.68405396 |
| 166 | Stomach cancer (HP:0012126) | 1.68228702 |
| 167 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.62493838 |
| 168 | Abnormal urine output (HP:0012590) | 1.62264963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 5.41316197 |
| 2 | EPHA4 | 3.29398728 |
| 3 | MAP3K9 | 3.12340249 |
| 4 | TNIK | 3.00237533 |
| 5 | MAP3K4 | 2.95897865 |
| 6 | MARK1 | 2.92871290 |
| 7 | BMPR1B | 2.81751219 |
| 8 | ZAK | 2.81611059 |
| 9 | ACVR1B | 2.72910811 |
| 10 | TLK1 | 2.62760724 |
| 11 | MAP2K7 | 2.57885776 |
| 12 | ADRBK2 | 2.54287440 |
| 13 | MAP4K2 | 2.38960213 |
| 14 | GRK1 | 2.33180159 |
| 15 | PRPF4B | 2.26778311 |
| 16 | CASK | 2.20679672 |
| 17 | RIPK4 | 2.08297369 |
| 18 | DAPK2 | 2.05279998 |
| 19 | WNK4 | 2.05242407 |
| 20 | PAK6 | 2.04880139 |
| 21 | MINK1 | 1.92238546 |
| 22 | NTRK2 | 1.88244922 |
| 23 | MAPK13 | 1.79542466 |
| 24 | PRKD3 | 1.67569619 |
| 25 | MAP2K4 | 1.53706443 |
| 26 | CDK5 | 1.43210196 |
| 27 | KSR2 | 1.41587110 |
| 28 | FGFR2 | 1.40494576 |
| 29 | STK38 | 1.40078472 |
| 30 | NTRK1 | 1.37668275 |
| 31 | NUAK1 | 1.36605755 |
| 32 | TRIM28 | 1.33680434 |
| 33 | SGK2 | 1.33595020 |
| 34 | FES | 1.28145164 |
| 35 | SGK494 | 1.28027076 |
| 36 | SGK223 | 1.28027076 |
| 37 | CAMKK1 | 1.24112556 |
| 38 | INSRR | 1.17479744 |
| 39 | MAP3K2 | 1.17056958 |
| 40 | MAPKAPK3 | 1.15139684 |
| 41 | BMPR2 | 1.14602377 |
| 42 | SIK2 | 1.14187652 |
| 43 | AKT3 | 1.12659490 |
| 44 | MAP3K13 | 1.12127633 |
| 45 | PLK2 | 1.11576452 |
| 46 | SGK3 | 1.09654778 |
| 47 | MKNK2 | 1.09292942 |
| 48 | DAPK1 | 1.08459008 |
| 49 | PRKCG | 1.05555039 |
| 50 | CAMK2A | 1.05319180 |
| 51 | CAMKK2 | 1.03976331 |
| 52 | KSR1 | 1.03409974 |
| 53 | ADRBK1 | 1.02585088 |
| 54 | MAP2K6 | 0.99262491 |
| 55 | SGK1 | 0.96850027 |
| 56 | WNK1 | 0.94928384 |
| 57 | TXK | 0.93476563 |
| 58 | PTK2B | 0.93389864 |
| 59 | CAMK2B | 0.93135136 |
| 60 | MARK2 | 0.90888968 |
| 61 | PKN1 | 0.90842485 |
| 62 | PHKG2 | 0.90731467 |
| 63 | PHKG1 | 0.90731467 |
| 64 | PAK3 | 0.90191598 |
| 65 | PRKCH | 0.89627973 |
| 66 | GRK5 | 0.86741523 |
| 67 | CAMK1G | 0.85547216 |
| 68 | NEK6 | 0.82877949 |
| 69 | UHMK1 | 0.82847778 |
| 70 | STK38L | 0.80458155 |
| 71 | OXSR1 | 0.78638393 |
| 72 | MST4 | 0.77846315 |
| 73 | ARAF | 0.77423729 |
| 74 | STK11 | 0.76478147 |
| 75 | NLK | 0.76459312 |
| 76 | CDC42BPA | 0.76100353 |
| 77 | TYRO3 | 0.74899905 |
| 78 | CAMK2D | 0.74777584 |
| 79 | PRKCE | 0.74302808 |
| 80 | MAP3K6 | 0.74156298 |
| 81 | RET | 0.73335950 |
| 82 | FER | 0.72326096 |
| 83 | FGR | 0.71249632 |
| 84 | PRKCI | 0.70091739 |
| 85 | CAMK1 | 0.69971160 |
| 86 | MAP3K12 | 0.68654504 |
| 87 | DYRK1A | 0.68281042 |
| 88 | PRKAA2 | 0.68188478 |
| 89 | PDK1 | 0.67843681 |
| 90 | TGFBR1 | 0.67384550 |
| 91 | PDPK1 | 0.66436451 |
| 92 | TEC | 0.65753656 |
| 93 | PNCK | 0.65274252 |
| 94 | RPS6KA5 | 0.63752445 |
| 95 | PIK3CG | 0.62762823 |
| 96 | ITK | 0.62503326 |
| 97 | MUSK | 0.59408183 |
| 98 | STK39 | 0.58984165 |
| 99 | TAOK3 | 0.58876505 |
| 100 | MAPKAPK5 | 0.58126144 |
| 101 | IKBKB | 0.57988204 |
| 102 | BRSK2 | 0.57603901 |
| 103 | VRK1 | 0.57216393 |
| 104 | RPS6KA3 | 0.56200942 |
| 105 | MAP3K1 | 0.55466162 |
| 106 | PRKCQ | 0.54816721 |
| 107 | JAK1 | 0.53595007 |
| 108 | CSNK1G1 | 0.52839570 |
| 109 | MAPK10 | 0.50778148 |
| 110 | TNK2 | 0.49961902 |
| 111 | PRKCZ | 0.49617849 |
| 112 | FYN | 0.49249965 |
| 113 | TRPM7 | 0.48617559 |
| 114 | MAP3K7 | 0.48207380 |
| 115 | MAP2K1 | 0.46442748 |
| 116 | PINK1 | 0.46225354 |
| 117 | CSNK1G2 | 0.45993756 |
| 118 | IRAK1 | 0.45854756 |
| 119 | CDK19 | 0.45005419 |
| 120 | SYK | 0.45003223 |
| 121 | WNK3 | 0.44158035 |
| 122 | CSNK1D | 0.43450094 |
| 123 | CDK18 | 0.43398265 |
| 124 | STK3 | 0.43389140 |
| 125 | CSNK1A1 | 0.43374404 |
| 126 | CDK15 | 0.42938214 |
| 127 | PDK4 | 0.42668588 |
| 128 | PDK3 | 0.42668588 |
| 129 | PRKCB | 0.41457702 |
| 130 | LMTK2 | 0.41136572 |
| 131 | CAMK4 | 0.39752860 |
| 132 | CAMK1D | 0.39341401 |
| 133 | RAF1 | 0.38894350 |
| 134 | PRKACA | 0.38448552 |
| 135 | CDK3 | 0.38332908 |
| 136 | CAMK2G | 0.38299872 |
| 137 | CHEK2 | 0.38149963 |
| 138 | PRKAA1 | 0.37724940 |
| 139 | PRKG1 | 0.37386586 |
| 140 | CDK14 | 0.37365620 |
| 141 | MAP3K14 | 0.36450611 |
| 142 | EIF2AK3 | 0.36287875 |
| 143 | NME1 | 0.35846484 |
| 144 | FRK | 0.35513912 |
| 145 | MAPK11 | 0.34252201 |
| 146 | PRKD2 | 0.34072352 |
| 147 | GSK3B | 0.33415559 |
| 148 | CSNK1G3 | 0.33391663 |
| 149 | PLK4 | 0.32151752 |
| 150 | MARK3 | 0.31538760 |
| 151 | CHUK | 0.30798791 |
| 152 | DYRK2 | 0.29700699 |
| 153 | PRKCA | 0.29562570 |
| 154 | ATR | 0.29361851 |
| 155 | MAPK15 | 0.29135245 |
| 156 | MAP4K1 | 0.28495903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.36191522 |
| 2 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.96939239 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.91870064 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.77173202 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.63254981 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.59271545 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.57503171 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.50732049 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.48612716 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.42339640 |
| 11 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.34929899 |
| 12 | Long-term potentiation_Homo sapiens_hsa04720 | 2.34405577 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.23586592 |
| 14 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.19905163 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.13697145 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.09131331 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.93712834 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.93645389 |
| 19 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.93426503 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.93027146 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 1.89265306 |
| 22 | Homologous recombination_Homo sapiens_hsa03440 | 1.87850389 |
| 23 | ABC transporters_Homo sapiens_hsa02010 | 1.87121765 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.85064203 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.83196350 |
| 26 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.80500416 |
| 27 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.78226036 |
| 28 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.76111829 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.74303625 |
| 30 | Renin secretion_Homo sapiens_hsa04924 | 1.69140776 |
| 31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.67530510 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.53633294 |
| 33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.51514541 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.49485557 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.49269882 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.47909229 |
| 37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.47432847 |
| 38 | Long-term depression_Homo sapiens_hsa04730 | 1.45424613 |
| 39 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.43967950 |
| 40 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.43205847 |
| 41 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.43034896 |
| 42 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.42392974 |
| 43 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.40062399 |
| 44 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.38674470 |
| 45 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.37390822 |
| 46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.36824422 |
| 47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.32750386 |
| 48 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.29866176 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.24644785 |
| 50 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.21323810 |
| 51 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.21103076 |
| 52 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.20367172 |
| 53 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.16628363 |
| 54 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.15124233 |
| 55 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.13725592 |
| 56 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.13640555 |
| 57 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.10363560 |
| 58 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.10201982 |
| 59 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.08386921 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.08115624 |
| 61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.07474070 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 1.06119608 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.01411133 |
| 64 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.01036735 |
| 65 | RNA polymerase_Homo sapiens_hsa03020 | 1.00882638 |
| 66 | Gap junction_Homo sapiens_hsa04540 | 1.00750722 |
| 67 | Histidine metabolism_Homo sapiens_hsa00340 | 1.00358073 |
| 68 | Basal transcription factors_Homo sapiens_hsa03022 | 0.98940817 |
| 69 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.98280282 |
| 70 | Axon guidance_Homo sapiens_hsa04360 | 0.97452889 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.96419816 |
| 72 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.95864111 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.94847749 |
| 74 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.94245550 |
| 75 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.94169033 |
| 76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.91329487 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.90684318 |
| 78 | Glioma_Homo sapiens_hsa05214 | 0.90669261 |
| 79 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.89103285 |
| 80 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.88487557 |
| 81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88193014 |
| 82 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.86830150 |
| 83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86391184 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84619306 |
| 85 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82956502 |
| 86 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.82488627 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.82439994 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81872204 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | 0.81565731 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.77992478 |
| 91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76963863 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76040952 |
| 93 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.75485042 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73677368 |
| 95 | Melanogenesis_Homo sapiens_hsa04916 | 0.72259599 |
| 96 | Peroxisome_Homo sapiens_hsa04146 | 0.72259299 |
| 97 | Protein export_Homo sapiens_hsa03060 | 0.72119642 |
| 98 | Asthma_Homo sapiens_hsa05310 | 0.70957529 |
| 99 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70918234 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.68786273 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66479055 |
| 102 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.65995561 |
| 103 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.64947907 |
| 104 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62136393 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59465167 |
| 106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59146849 |
| 107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.57982047 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57869170 |
| 109 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.57529148 |
| 110 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.56874697 |
| 111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56437814 |
| 112 | RNA degradation_Homo sapiens_hsa03018 | 0.55053468 |
| 113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55023887 |
| 114 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54412021 |
| 115 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53169849 |
| 116 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.52614424 |
| 117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51876616 |
| 118 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.51696525 |
| 119 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50756845 |
| 120 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.50741327 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50665624 |
| 122 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.50403383 |
| 123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49942011 |
| 124 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.49480073 |
| 125 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49193489 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48391007 |
| 127 | Purine metabolism_Homo sapiens_hsa00230 | 0.47973925 |
| 128 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47363782 |
| 129 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46489809 |
| 130 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46116462 |
| 131 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46034126 |
| 132 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.45852118 |
| 133 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44874894 |
| 134 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.44181011 |
| 135 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44031024 |
| 136 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43431570 |
| 137 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41996202 |
| 138 | Endocytosis_Homo sapiens_hsa04144 | 0.41655048 |
| 139 | Prion diseases_Homo sapiens_hsa05020 | 0.40782818 |
| 140 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40330535 |
| 141 | Lysine degradation_Homo sapiens_hsa00310 | 0.39965138 |
| 142 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.39802208 |
| 143 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39707442 |
| 144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37145229 |
| 145 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36765467 |
| 146 | Alcoholism_Homo sapiens_hsa05034 | 0.33792493 |
| 147 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.33622235 |
| 148 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32696469 |
| 149 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31369311 |
| 150 | Bile secretion_Homo sapiens_hsa04976 | 0.30951926 |
| 151 | Mineral absorption_Homo sapiens_hsa04978 | 0.30827402 |
| 152 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.30488872 |
| 153 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.29321778 |
| 154 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.29320133 |

